西地那非可增强对吸入一氧化氮的反应。 - Suppr

Sildenafil can increase the response to inhaled nitric oxide.

作者信息

Bigatello L M, Hess D, Dennehy K C, Medoff B D, Hurford W E

机构信息

Departments of Anesthesia and Critical Care, Respiratory Care Services, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

Anesthesiology. 2000 Jun;92(6):1827-9. doi: 10.1097/00000542-200006000-00044.

DOI:10.1097/00000542-200006000-00044

PMID:10839936

Abstract

摘要

相似文献

Sildenafil can increase the response to inhaled nitric oxide.

Anesthesiology. 2000 Jun;92(6):1827-9. doi: 10.1097/00000542-200006000-00044.

Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension.

Intern Med. 2004 Oct;43(10):891-3. doi: 10.2169/internalmedicine.43.891.

Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.

Curr Opin Pharmacol. 2005 Jun;5(3):245-50. doi: 10.1016/j.coph.2004.12.008.

Tachyphylaxis and phosphodiesterase type 5 inhibitors.

J Urol. 2002 Jul;168(1):207.

[Erectile dysfunction: an update on new therapeutic options].

Acta Urol Belg. 2000;68(2):41-2.

Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia.

Pediatr Crit Care Med. 2004 Mar;5(2):184-7. doi: 10.1097/01.pcc.0000113266.26638.ad.

Inhaled nitric oxide in pediatric cardiac surgery.

Int Anesthesiol Clin. 2004 Fall;42(4):93-100. doi: 10.1097/00004311-200404240-00010.

Sildenafil for enhanced performance at high altitude?

Ann Intern Med. 2004 Aug 3;141(3):233-5. doi: 10.7326/0003-4819-141-3-200408030-00016.

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.

Curr Heart Fail Rep. 2004 Dec;1(4):183-9. doi: 10.1007/s11897-004-0007-6.

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.

Anesthesiology. 1999 Jul;91(1):307-10. doi: 10.1097/00000542-199907000-00041.

引用本文的文献

Pulmonary Hypertension in Intensive Care Units: An Updated Review.

Tanaffos. 2019 Mar;18(3):180-207.

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.

Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):257-90. doi: 10.5339/gcsp.2014.42. eCollection 2014.

Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism.

Intensive Care Med. 2006 Mar;32(3):452-4. doi: 10.1007/s00134-005-0058-5. Epub 2006 Feb 1.

Sildenafil--a possible treatment for acute pulmonary hypertension during cardiac surgery.

Proc (Bayl Univ Med Cent). 2002 Jan;15(1):13-5. doi: 10.1080/08998280.2002.11927806.

Sildenafil for pulmonary hypertension.

Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD003562. doi: 10.1002/14651858.CD003562.pub2.

Current management of primary pulmonary hypertension.

Drugs. 2001;61(13):1945-56. doi: 10.2165/00003495-200161130-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Sildenafil can increase the response to inhaled nitric oxide.

Anesthesiology. 2000 Jun;92(6):1827-9. doi: 10.1097/00000542-200006000-00044.

Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension.

Intern Med. 2004 Oct;43(10):891-3. doi: 10.2169/internalmedicine.43.891.

Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.

Curr Opin Pharmacol. 2005 Jun;5(3):245-50. doi: 10.1016/j.coph.2004.12.008.

Tachyphylaxis and phosphodiesterase type 5 inhibitors.

J Urol. 2002 Jul;168(1):207.

[Erectile dysfunction: an update on new therapeutic options].

Acta Urol Belg. 2000;68(2):41-2.

Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia.

Pediatr Crit Care Med. 2004 Mar;5(2):184-7. doi: 10.1097/01.pcc.0000113266.26638.ad.

Inhaled nitric oxide in pediatric cardiac surgery.

Int Anesthesiol Clin. 2004 Fall;42(4):93-100. doi: 10.1097/00004311-200404240-00010.

Sildenafil for enhanced performance at high altitude?

Ann Intern Med. 2004 Aug 3;141(3):233-5. doi: 10.7326/0003-4819-141-3-200408030-00016.

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.

Curr Heart Fail Rep. 2004 Dec;1(4):183-9. doi: 10.1007/s11897-004-0007-6.

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.

Anesthesiology. 1999 Jul;91(1):307-10. doi: 10.1097/00000542-199907000-00041.

引用本文的文献

Pulmonary Hypertension in Intensive Care Units: An Updated Review.

Tanaffos. 2019 Mar;18(3):180-207.

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.

Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):257-90. doi: 10.5339/gcsp.2014.42. eCollection 2014.

Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism.

Intensive Care Med. 2006 Mar;32(3):452-4. doi: 10.1007/s00134-005-0058-5. Epub 2006 Feb 1.

Sildenafil--a possible treatment for acute pulmonary hypertension during cardiac surgery.

Proc (Bayl Univ Med Cent). 2002 Jan;15(1):13-5. doi: 10.1080/08998280.2002.11927806.

Sildenafil for pulmonary hypertension.

Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD003562. doi: 10.1002/14651858.CD003562.pub2.

Current management of primary pulmonary hypertension.

Drugs. 2001;61(13):1945-56. doi: 10.2165/00003495-200161130-00005.

Sildenafil can increase the response to inhaled nitric oxide.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Sildenafil can increase the response to inhaled nitric oxide.

作者信息

机构信息

出版信息

相似文献

引用本文的文献